{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T07:23:14Z","timestamp":1773300194558,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2014,1,4]],"date-time":"2014-01-04T00:00:00Z","timestamp":1388793600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1007\/s00296-013-2935-5","type":"journal-article","created":{"date-parts":[[2014,1,3]],"date-time":"2014-01-03T15:22:52Z","timestamp":1388762572000},"page":"963-970","source":"Crossref","is-referenced-by-count":32,"title":["Allopurinol use in a New Zealand population: prevalence and adherence"],"prefix":"10.1007","volume":"34","author":[{"given":"Simon","family":"Horsburgh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pauline","family":"Norris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordon","family":"Becket","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Arroll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Crampton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline","family":"Cumming","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shirley","family":"Keown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Herbison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,1,4]]},"reference":[{"key":"2935_CR1","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1185\/03007995.2010.533647","volume":"26","author":"RA Brook","year":"2010","unstructured":"Brook RA, Forsythe A, Smeeding JE, Lawrence Edwards N (2010) Chronic gout: epidemiology, disease progression, treatment and disease burden. Curr Med Res Opin 26:2813\u20132821. doi: 10.1185\/03007995.2010.533647","journal-title":"Curr Med Res Opin"},{"key":"2935_CR2","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.berh.2010.10.004","volume":"24","author":"EUR Smith","year":"2010","unstructured":"Smith EUR, D\u00edaz-Torn\u00e9 C, Perez-Ruiz F, March LM (2010) Epidemiology of gout: an update. Best Pract Res Clin Rheumatol 24:811\u2013827. doi: 10.1016\/j.berh.2010.10.004","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2935_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/RHU.0b013e318204a8f9","volume":"17","author":"K Lindsay","year":"2011","unstructured":"Lindsay K, Gow P, Vanderpyl J et al (2011) The experience and impact of living with gout: a study of men with chronic gout using a qualitative grounded theory approach. J Clin Rheumatol 17:1\u20136. doi: 10.1097\/RHU.0b013e318204a8f9","journal-title":"J Clin Rheumatol"},{"key":"2935_CR4","first-page":"79","volume":"121","author":"D Winnard","year":"2008","unstructured":"Winnard D, Kake T, Gow P et al (2008) Debunking the myths to provide 21st Century management of gout. N Z Med J 121:79\u201385","journal-title":"N Z Med J"},{"key":"2935_CR5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/RHU.0b013e31824e1f6f","volume":"18","author":"N Martini","year":"2012","unstructured":"Martini N, Bryant L, Te Karu L et al (2012) Living with gout in New Zealand: an exploratory study into people\u2019s knowledge about the disease and its treatment. J Clin Rheumatol 18:125\u2013129. doi: 10.1097\/RHU.0b013e31824e1f6f","journal-title":"J Clin Rheumatol"},{"key":"2935_CR6","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1524-4733.2007.00173.x","volume":"10","author":"NL Kleinman","year":"2007","unstructured":"Kleinman NL, Brook RA, Patel PA et al (2007) The impact of gout on work absence and productivity. Value Heal 10:231\u2013237. doi: 10.1111\/j.1524-4733.2007.00173.x","journal-title":"Value Heal"},{"key":"2935_CR7","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/rheumatology\/ker361","volume":"51","author":"D Winnard","year":"2012","unstructured":"Winnard D, Wright C, Taylor WJ et al (2012) National prevalence of gout derived from administrative health data in Aotearoa New Zealand. Rheumatology 51:901\u2013909. doi: 10.1093\/rheumatology\/ker361","journal-title":"Rheumatology"},{"key":"2935_CR8","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1093\/rheumatology\/kes147","volume":"51","author":"G Jackson","year":"2012","unstructured":"Jackson G, Wright C, Thornley S et al (2012) Potential unmet need for gout diagnosis and treatment: capture-recapture analysis of a national administrative dataset. Rheumatology 51:1820\u20131824. doi: 10.1093\/rheumatology\/kes147","journal-title":"Rheumatology"},{"key":"2935_CR9","author":"G Trifir\u00f2","year":"2012","unstructured":"Trifir\u00f2 G, Morabito P, Cavagna L et al (2012) Epidemiology of gout and hyperuricaemia in Italy during the years 2005\u20132009: a nationwide population-based study. Ann Rheum Dis. doi: 10.1136\/annrheumdis-2011-201254","journal-title":"Ann Rheum Dis"},{"key":"2935_CR10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/01.bor.0000209435.89720.7c","volume":"18","author":"TR Mikuls","year":"2006","unstructured":"Mikuls TR, Saag KG (2006) New insights into gout epidemiology. Curr Opin Rheumatol 18:199\u2013203. doi: 10.1097\/01.bor.0000209435.89720.7c","journal-title":"Curr Opin Rheumatol"},{"key":"2935_CR11","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/j.1445-5994.2012.02794.x","volume":"42","author":"PC Robinson","year":"2012","unstructured":"Robinson PC, Taylor WJ, Merriman TR (2012) A systematic review of the prevalence of gout and hyperuricemia in Australia. Intern Med J 42:997\u20131007. doi: 10.1111\/j.1445-5994.2012.02794.x","journal-title":"Intern Med J"},{"key":"2935_CR12","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/rheumatology\/keq363","volume":"50","author":"D Rothenbacher","year":"2011","unstructured":"Rothenbacher D, Primatesta P, Ferreira A et al (2011) Frequency and risk factors of gout flares in a large population-based cohort of incident gout. Rheumatology 50:973\u2013981. doi: 10.1093\/rheumatology\/keq363","journal-title":"Rheumatology"},{"key":"2935_CR13","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1136\/ard.2010.136218","volume":"69","author":"N Dalbeth","year":"2010","unstructured":"Dalbeth N, So A (2010) Hyperuricaemia and gout: state of the art and future perspectives. Ann Rheum Dis 69:1738\u20131743. doi: 10.1136\/ard.2010.136218","journal-title":"Ann Rheum Dis"},{"key":"2935_CR14","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1517\/14656560902950742","volume":"10","author":"N Schlesinger","year":"2009","unstructured":"Schlesinger N, Dalbeth N, Perez-Ruiz F (2009) Gout\u2013what are the treatment options? Expert Opin Pharmacother 10:1319\u20131328. doi: 10.1517\/14656560902950742","journal-title":"Expert Opin Pharmacother"},{"key":"2935_CR15","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jbspin.2011.05.010","volume":"78","author":"G Reach","year":"2011","unstructured":"Reach G (2011) Treatment adherence in patients with gout. Joint, Bone, Spine 78:456\u2013459. doi: 10.1016\/j.jbspin.2011.05.010","journal-title":"Joint, Bone, Spine"},{"key":"2935_CR16","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1592\/phco.28.4.437","volume":"28","author":"BA Briesacher","year":"2008","unstructured":"Briesacher BA, Andrade SE, Fouayzi H, Chan KA (2008) Comparison of drug adherence rates among patients with seven different medical conditions. Pharmacotherapy 28:437\u2013443. doi: 10.1592\/phco.28.4.437","journal-title":"Pharmacotherapy"},{"key":"2935_CR17","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1136\/ard.2007.076182","volume":"67","author":"DH Solomon","year":"2008","unstructured":"Solomon DH, Avorn J, Levin R, Brookhart MA (2008) Uric acid lowering therapy: prescribing patterns in a large cohort of older adults. Ann Rheum Dis 67:609\u2013613. doi: 10.1136\/ard.2007.076182","journal-title":"Ann Rheum Dis"},{"key":"2935_CR18","doi-asserted-by":"crossref","first-page":"R46","DOI":"10.1186\/ar2659","volume":"11","author":"LR Harrold","year":"2009","unstructured":"Harrold LR, Andrade SE, Briesacher BA et al (2009) Adherence with urate-lowering therapies for the treatment of gout. Arthritis Res Ther 11:R46. doi: 10.1186\/ar2659","journal-title":"Arthritis Res Ther"},{"key":"2935_CR19","doi-asserted-by":"crossref","first-page":"A8","DOI":"10.1002\/anr.1790020309","volume":"2","author":"J Dunbar","year":"1989","unstructured":"Dunbar J, Dunning EJ, Dwyer K (1989) Compliance measurement with arthritis regimen. Arthritis Care Res (Hoboken) 2:A8\u2013A16. doi: 10.1002\/anr.1790020309","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2935_CR20","volume-title":"Prescribing and dispensing data sources in New Zealand: their usage and future directions","author":"S Horsburgh","year":"2009","unstructured":"Horsburgh S, Malik M, Norris P et al (2009) Prescribing and dispensing data sources in New Zealand: their usage and future directions. School of Pharmacy, Dunedin"},{"key":"2935_CR21","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jbi.2010.08.004","volume":"43","author":"S Horsburgh","year":"2010","unstructured":"Horsburgh S, Norris P, Becket G et al (2010) The equity in prescription medicines use study: using community pharmacy databases to study medicines utilisation. J Biomed Inform 43:982\u2013987. doi: 10.1016\/j.jbi.2010.08.004","journal-title":"J Biomed Inform"},{"key":"2935_CR22","volume-title":"QuickStats about Gisborne District","author":"Statistics New Zealand","year":"2009","unstructured":"Statistics New Zealand (2009) QuickStats about Gisborne District. Statistics New Zealand, Wellington"},{"key":"2935_CR23","unstructured":"Salmond C, Crampton P, Atkinson J (2007) NZDep2006 index of deprivation. Department of Public Health, University of Otago, Wellington"},{"key":"2935_CR24","unstructured":"Statistics New Zealand (2013) Urban\/rural profile (experimental) classification categories. http:\/\/www.stats.govt.nz\/methods\/classifications-and-standards\/urban-rural-profile-experimental-class-categories.aspx . Accessed 13 Feb 2013"},{"key":"2935_CR25","volume-title":"Guidelines for ATC classification and DDD assignment","author":"WHO Collaborating Centre for Drug Statistics Methodology","year":"2007","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology (2007) Guidelines for ATC classification and DDD assignment. WHO Collaborating Centre for Drug Statistics Methodology, Oslo"},{"key":"2935_CR26","unstructured":"Apotex NZ Ltd (2011) New Zealand data sheet: Apo-Allopurinol. Apotex NZ Ltd, Auckland"},{"key":"2935_CR27","doi-asserted-by":"crossref","unstructured":"Andrade SE, Kahler KH, Frech F, Chan KA (2006) Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf 15:565\u2013574; discussion 575\u2013577. doi: 10.1002\/pds.1230","DOI":"10.1002\/pds.1230"},{"key":"2935_CR28","volume-title":"Modern epidemiology","author":"KJ Rothman","year":"2008","unstructured":"Rothman KJ, Greenland S, Lash TL (2008) Modern epidemiology, 3rd edn. Lippincott Williams & Wilkins, Philadelphia","edition":"3"},{"key":"2935_CR29","unstructured":"R Core Team (2012) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna"},{"key":"2935_CR30","author":"N Dalbeth","year":"2012","unstructured":"Dalbeth N, House ME, Horne A et al (2012) The experience and impact of gout in M\u0101ori and Pacific people: a prospective observational study. Clin Rheumatol. doi: 10.1007\/s10067-012-2110-5","journal-title":"Clin Rheumatol"},{"key":"2935_CR31","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/1742395310378761","volume":"6","author":"LR Harrold","year":"2010","unstructured":"Harrold LR, Mazor KM, Velten S et al (2010) Patients and providers view gout differently: a qualitative study. Chronic Illn 6:263\u2013271. doi: 10.1177\/1742395310378761","journal-title":"Chronic Illn"},{"key":"2935_CR32","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/annrheumdis-2011-200801","volume":"71","author":"K Spencer","year":"2012","unstructured":"Spencer K, Carr A, Doherty M (2012) Patient and provider barriers to effective management of gout in general practice: a qualitative study. Ann Rheum Dis 71:1490\u20131495. doi: 10.1136\/annrheumdis-2011-200801","journal-title":"Ann Rheum Dis"},{"key":"2935_CR33","volume-title":"The social report","author":"Ministry of Social Development","year":"2010","unstructured":"Ministry of Social Development (2010) The social report. Ministry of Social Development, Wellington"},{"key":"2935_CR34","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1136\/jech.2009.099101","volume":"65","author":"S Jatrana","year":"2011","unstructured":"Jatrana S, Crampton P, Norris P (2011) Ethnic differences in access to prescription medication because of cost in New Zealand. J Epidemiol Community Health 65:454\u2013460. doi: 10.1136\/jech.2009.099101","journal-title":"J Epidemiol Community Health"},{"key":"2935_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.healthpol.2009.05.006","volume":"93","author":"S Jatrana","year":"2009","unstructured":"Jatrana S, Crampton P (2009) Primary health care in New Zealand: who has access? Health Policy (New York) 93:1\u201310. doi: 10.1016\/j.healthpol.2009.05.006","journal-title":"Health Policy (New York)"},{"key":"2935_CR36","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/acr.20570","volume":"63","author":"N Dalbeth","year":"2011","unstructured":"Dalbeth N, Petrie KJ, House M et al (2011) Illness perceptions in patients with gout and the relationship with progression of musculoskeletal disability. Arthritis Care Res (Hoboken) 63:1605\u20131612. doi: 10.1002\/acr.20570","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2935_CR37","unstructured":"Davis A (2012) Geographical access to medicines in Te Tairawhiti. University of Otago"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-013-2935-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-013-2935-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-013-2935-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T19:59:25Z","timestamp":1565035165000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-013-2935-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,4]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["2935"],"URL":"https:\/\/doi.org\/10.1007\/s00296-013-2935-5","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,4]]}}}